Literature DB >> 7996464

Enhanced permeability of tetragastrin across the rat intestinal membrane and its reduced degradation by acylation with various fatty acids.

E Yodoya1, K Uemura, T Tenma, T Fujita, M Murakami, A Yamamoto, S Muranishi.   

Abstract

Three types of chemically modified tetragastrin (TG) with fatty acids such as acetyl-TG, caproyl-TG and lauroyl-TG were synthesized and their in vitro intestinal permeability characteristics were estimated by a modified Ussing chamber system using the isolated intestinal membrane of rats. The penetration of TG across the large intestine was increased by conjugation with acetic acid and caproic acid but not lauric acid. Lauroyl-TG, a highly lipophilic derivative, exhibited low permeability across the intestinal membrane. A "bell-shaped" profile was observed between the apparent permeability coefficients and lipophilicity of the acyl-TG derivatives. The stability of acyl-TG derivatives was examined in homogenates of the jejunum, proximal and distal large intestine, liver and plasma. The half-lives for the proteolysis of the TGs were significantly prolonged by chemical modification with fatty acids in each homogenate. Thus, the chemical modification of TG with some fatty acids not only increases the lipophilicity of TG but also reduces its degradation, which resulted in increased intestinal absorption. The extent of the conjugates' hepatic first-pass metabolism was evaluated by gastric acid secretion activities after i.v. and intraportal administration. The amount of gastric acid secretion after intraportal administration of TG was significantly reduced in comparison with that after i.v. administration. On the other hand, conjugation with caproic acid slightly suppressed TG's hepatic first-pass metabolism, which suggests that chemically modified TGs with fatty acids would be more stable than the native TG in the systemic circulation after intestinal absorption.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7996464

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

1.  Development of novel lipophilic derivatives of DADLE (leucine enkephalin analogue): intestinal permeability characateristics of DADLE derivatives in rats.

Authors:  T Uchiyama; A Kotani; H Tatsumi; T Kishida; A Okamoto; N Okada; M Murakami; T Fujita; Y Fujiwara; Y Kiso; S Muranishi; A Yamamoto
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

2.  Preparation, purification, and characterization of a reversibly lipidized desmopressin with potentiated anti-diuretic activity.

Authors:  J Wang; D Shen; W C Shen
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

3.  Comparison of pharmacokinetic parameters of a polypeptide, the Bowman-Birk protease inhibitor (BBI), and its palmitic acid conjugate.

Authors:  L Honeycutt; J Wang; H Ekrami; W C Shen
Journal:  Pharm Res       Date:  1996-09       Impact factor: 4.200

4.  Position of lipidation influences anticancer activity of Smac analogs.

Authors:  Ewa D Micewicz; Christine Nguyen; Alina Micewicz; Alan J Waring; William H McBride; Piotr Ruchala
Journal:  Bioorg Med Chem Lett       Date:  2019-04-26       Impact factor: 2.823

5.  Lipid-conjugated Smac analogues.

Authors:  Ewa D Micewicz; Josephine A Ratikan; Alan J Waring; Julian P Whitelegge; William H McBride; Piotr Ruchala
Journal:  Bioorg Med Chem Lett       Date:  2015-09-08       Impact factor: 2.823

6.  Permeability characteristics of tetragastrins across intestinal membranes using the Caco-2 monolayer system: comparison between acylation and application of protease inhibitors.

Authors:  T Fujita; I Kawahara; Y Quan; K Hattori; K Takenaka; S Muranishi; A Yamamoto
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

7.  Permeabilities of rebamipide via rat intestinal membranes and its colon specific delivery using chitosan capsule as a carrier.

Authors:  Bei-Bei Huang; Guo-Feng Li; Jing-Hui Luo; Lian Duan; Kishimoto Nobuaki; Yamamoto Akira
Journal:  World J Gastroenterol       Date:  2008-08-21       Impact factor: 5.742

8.  Structure-activity relationship of reversibly lipidized peptides: studies of fatty acid-desmopressin conjugates.

Authors:  Jeff Wang; Daphne Wu; Wei-Chiang Shen
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

9.  Aqueous-soluble, non-reversible lipid conjugate of salmon calcitonin: synthesis, characterization and in vivo activity.

Authors:  Weiqiang Cheng; Seetharama Satyanarayanajois; Lee-Yong Lim
Journal:  Pharm Res       Date:  2006-11-16       Impact factor: 4.580

10.  A two-step strategy to enhance activity of low potency peptides.

Authors:  Jamie R Doyle; Benjamin N Harwood; Subrahmanian Tarakkad Krishnaji; Vijay M Krishnamurthy; Wei-En Lin; Jean-Philippe Fortin; Krishna Kumar; Alan S Kopin
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.